Hu Zhou

1.9k total citations
59 papers, 1.1k citations indexed

About

Hu Zhou is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Hu Zhou has authored 59 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 13 papers in Cellular and Molecular Neuroscience and 9 papers in Organic Chemistry. Recurrent topics in Hu Zhou's work include Retinoids in leukemia and cellular processes (18 papers), Nuclear Receptors and Signaling (13 papers) and Estrogen and related hormone effects (9 papers). Hu Zhou is often cited by papers focused on Retinoids in leukemia and cellular processes (18 papers), Nuclear Receptors and Signaling (13 papers) and Estrogen and related hormone effects (9 papers). Hu Zhou collaborates with scholars based in China, United States and Hong Kong. Hu Zhou's co-authors include Xiao-kun Zhang, Ying Su, Zhiping Zeng, Ying Su, Ye‐Guang Chen, Anming Meng, Long Zhang, Liqun Chen, Xuehui An and Xiao-kun Zhang and has published in prestigious journals such as Science, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Hu Zhou

58 papers receiving 1.1k citations

Peers

Countries citing papers authored by Hu Zhou

Since Specialization

Citations

This map shows the geographic impact of Hu Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hu Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hu Zhou more than expected).

Fields of papers citing papers by Hu Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hu Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hu Zhou. The network helps show where Hu Zhou may publish in the future.

Co-authorship network of co-authors of Hu Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Hu Zhou. A scholar is included among the top collaborators of Hu Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hu Zhou. Hu Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Global, regional, and national burden of fracture of sternum and/or fracture of one or more ribs: a systematic analysis of incidence, YLDs with projections to 2030 2025 ·Frontiers in Public Health ·Zhizhi Wang, (unknown), (unknown), Huajie Li, Hu Zhou, (unknown), (unknown), (unknown), Kaican Cai, Zhiming Chen	0
2	Epidemiological trends and burden analysis of cervical cancer attributable to unsafe sex: A population‐based study from 1990 to 2019 2024 ·Public Health Nursing ·(unknown), Xingxing Zhang, (unknown), (unknown), (unknown), Hu Zhou, Xi Li, Yu Guo, (unknown), (unknown)	1
3	Global burden of mesothelioma attributable to occupational asbestos exposure in 204 countries and territories: 1990–2019 2024 ·Journal of Cancer Research and Clinical Oncology ·(unknown), (unknown), (unknown), Hu Zhou, Huajie Li, Zhizhi Wang, Kaican Cai	6
4	Discovery of 5-(Pyrimidin-2-ylamino)-1H-indole-2-carboxamide Derivatives as Nur77 Modulators with Selective and Potent Activity Against Triple-Negative Breast Cancer 2023 ·Journal of Medicinal Chemistry ·(unknown), Boning Niu, Xiaohong Chen, (unknown), Sheng Lu, Hongsheng Li, Weihao Liu, Jiayi Li, (unknown), (unknown), Hongyu Hu, Yang Xu, Shuaidong Huo, Zhenhua Wu, Ying‐Kun Qiu, Hu Zhou, Meijuan Fang	9
5	Precise delivery of celastrol by PEGylated aptamer dendrimer nanoconjugates for enormous therapeutic effect via superior intratumor penetration over antibody counterparts 2023 ·Cancer Letters ·Boning Niu, Yuehuang Wu, Min Zhou, (unknown), (unknown), Xiaohong Chen, Hu Zhou, Xiao-kun Zhang, Jingjing Xie	16
6	Three birds with one stone: co-encapsulation of diclofenac and DL-menthol for realizing enhanced energy deposition, glycolysis inhibition and anti-inflammation in HIFU surgery 2022 ·Journal of Nanobiotechnology ·Haitao Wu, Hu Zhou, Wenjie Zhang, (unknown), Qianqian Shi, Zhaohua Miao, Hua Wang, Zhengbao Zha	6
7	Interplay between transforming growth factor-β and Nur77 in dual regulations of inhibitor of differentiation 1 for colonic tumorigenesis 2021 ·Nature Communications ·Boning Niu, Jie Liu, Ben Lv, Jiacheng Lin, Xin Li, Chunxiao Wu, Xiaohua Jiang, Zhiping Zeng, Xiao-kun Zhang, Hu Zhou	28
8	Design, synthesis, and biological evaluation of novel sulindac derivatives as partial agonists of PPARγ with potential anti-diabetic efficacy 2021 ·European Journal of Medicinal Chemistry ·Fengyu Huang, Zhiping Zeng, Weidong Zhang, Zhiqiang Yan, Jiayun Chen, (unknown), Qian Yang, (unknown), Hongyu Yu, Junjie Chen, Caisheng Wu, Xiao-kun Zhang, Ying Su, Hu Zhou	9
9	Merbromin is a mixed-type inhibitor of 3-chyomotrypsin like protease of SARS-CoV-2 2021 ·Biochemical and Biophysical Research Communications ·Junjie Chen, Yaya Zhang, Dequan Zeng, Bingchang Zhang, Xiaohong Ye, Zhiping Zeng, Xiao-kun Zhang, Zhanxiang Wang, Hu Zhou	6
10	Rosiglitazone binds to RXRα to induce RXRα tetramerization and NB4 cell differentiation 2020 ·Biochemical and Biophysical Research Communications ·Fengyu Huang, (unknown), Junjie Chen, Xiao-kun Zhang, Hu Zhou	2
11	Norlichexanthone purified from plant endophyte prevents postmenopausal osteoporosis by targeting ER to inhibit RANKL signaling 2020 ·Acta Pharmaceutica Sinica B ·Keqi Wang, (unknown), Shuo Gao, (unknown), Meng-Meng Ge, Qian Yang, (unknown), Lin Xu, Junjie Chen, Zhiping Zeng, Haifeng Chen, Xiao-kun Zhang, Ting Lin, Hu Zhou	17
12	BI1071, a Novel Nur77 Modulator, Induces Apoptosis of Cancer Cells by Activating the Nur77-Bcl-2 Apoptotic Pathway 2019 ·Molecular Cancer Therapeutics ·Xiaohong Chen, Xihua Cao, (unknown), Gulimiran Alitongbieke, Zebin Xia, Xiaotong Li, Ziwen Chen, Meimei Yin, Dan Xu, (unknown), Zongxi Li, Liqun Chen, (unknown), (unknown), (unknown), Jie Liu, Zhiping Zeng, Hu Zhou, Ying Su, Xiao-kun Zhang	27
13	NSC-640358 acts as RXRα ligand to promote TNFα-mediated apoptosis of cancer cell 2015 ·Protein & Cell ·Fan Chen, Jiebo Chen, Jiacheng Lin, Anton Cheltsov, Lin Xu, Ya Chen, Zhiping Zeng, Liqun Chen, Mingfeng Huang, Mengjie Hu, Xiaohong Ye, Yuqi Zhou, Guanghui Wang, Ying Su, Long Zhang, Fangfang Zhou, Xiao-kun Zhang, Hu Zhou	8
14	Targeting truncated RXRα for cancer therapy 2015 ·Acta Biochimica et Biophysica Sinica ·Xiao-kun Zhang, Hu Zhou, Ying Su	24
15	Sulindac-Derived RXRα Modulators Inhibit Cancer Cell Growth by Binding to a Novel Site 2014 ·Chemistry & Biology ·Long‐Qing Chen, Zhigang Wang, Alexander E. Aleshin, (unknown), Jiebo Chen, Fuquan Jiang, Gulimiran Alitongbieke, Zhiping Zeng, (unknown), Mingfeng Huang, Hu Zhou, G. Cadwell, Jianfeng Zheng, Pei‐Qiang Huang, Robert Liddington, Xiao-kun Zhang, Ying Su	34
16	Regulation of the nongenomic actions of retinoid X receptor-α by targeting the coregulator-binding sites 2014 ·Acta Pharmacologica Sinica ·Xiao-kun Zhang, Ying Su, Liqun Chen, Fan Chen, Jie Liu, Hu Zhou	37
17	Synthesis and SAR study of modulators inhibiting tRXRα-dependent AKT activation 2013 ·European Journal of Medicinal Chemistry ·Zhigang Wang, Long‐Qing Chen, Jiebo Chen, Jianfeng Zheng, Weiwei Gao, Zhiping Zeng, Hu Zhou, Xiao-kun Zhang, Pei‐Qiang Huang, Ying Su	13
18	Targeting Truncated Retinoid X Receptor-α by CF31 Induces TNF-α–Dependent Apoptosis 2012 ·Cancer Research ·Guanghui Wang, Fuquan Jiang, Yinghui Duan, Zhiping Zeng, Fan Chen, Yi Dai, Jiebo Chen, Jin‐Xing Liu, Jie Liu, Hu Zhou, Haifeng Chen, Jin-Zhang Zeng, Ying Su, Xin‐Sheng Yao, Xiao-kun Zhang	34
19	Combination of Valproic Acid and ATRA Restores RARβ2 Expression and Induces Differentiation in Cervical Cancer through the PI3K/Akt Pathway 2012 ·Current Molecular Medicine ·Dingqing Feng, Zhe Cao, (unknown), (unknown), Ying Zhou, Jiajia Ma, (unknown), Hu Zhou, Wensheng Zhao, Haiming Wei, Bin Ling	21
20	Zebrafish Dpr2 Inhibits Mesoderm Induction by Promoting Degradation of Nodal Receptors 2004 ·Science ·Lixia Zhang, Hu Zhou, Ying Su, Zhihui Sun, Haiwen Zhang, Long Zhang, Yu Zhang, Yuanheng Ning, Ye‐Guang Chen, Anming Meng	118

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact